Associated Papers
Association of Matrix Metalloproteinases Polymorphisms with Glaucoma Risk, Glaucoma Phenotype, and Response to Treatment with Selective Laser Trabeculoplasty or Latanoprost.
Atanasovska Velkovska M et al.
International Journal of Molecular Sciences, 2024
39769228 (PubMed )
Supplement: ijms-25-13464-s001.zip › ijms-3311215-supplementary.pdf
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.
Toulmonde M et al.
Ebiomedicine, 2020
33254023 (PubMed )
Supplement: mmc5.xlsx › UPS_somatic_mutations_filtered
Matrix Metalloproteinases Polymorphisms as Baseline Risk Predictors in Malignant Pleural Mesothelioma.
Strbac D et al.
Radiology and Oncology, 2018
Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma.
Štrbac D et al.
Disease Markers, 2017
Targeted and exome sequencing identified somatic mutations in hepatocellular carcinoma.
Hirotsu Y et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology, 2016
26850916 (PubMed )
Supplement: supplement_1.xlsx › Table_S6
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Tang X et al.
Nucleic Acids Research, 2014
25352556 (PubMed )
Supplement: supp_gku1005_nar-01266-met-n-2014-File012.xlsx › TCGA-A2-A0CT-01A.domain
Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma.
Chen TY et al.
Annals of Surgical Oncology, 2011
MMP14 gene polymorphisms in chronic obstructive pulmonary disease.
Saitoh W et al.
International Journal of Molecular Medicine, 2006
Select a paper to view details